Compare Immunovant Inc. Common Stock (IMVT) vs Vishay Intertechnology Inc. Common Stock (VSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Vishay Intertechnology Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.57 (market cap $6.25B), while Vishay Intertechnology Inc. Common Stock trades at $34.09 (market cap $5.30B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Vishay Intertechnology Inc. Common Stock pays a 1.16% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Vishay Intertechnology Inc. Common Stock for 1 Days on average.
| IMVT | VSH | |
|---|---|---|
Market Cap | $6.25B | $5.30B |
Volume | 1,755,411 | 3,213,272 |
Sector | Health | Technology |
52-Week High | $44.96 | $64.90 |
52-Week Low | $17.03 | $11.82 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.35B | $5.10B |
Dividend Yield | — | 1.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Vishay Intertechnology Inc. Common Stock
Vishay Intertechnology manufactures discrete semiconductors and passive electronic components. Its products include diodes, MOSFETs, resistors, capacitors, and sensors.
Read more on VSH →
